152 related articles for article (PubMed ID: 11378679)
1. Monitoring the treatment of sepsis with vancomycin in term newborn infants.
Machado JK; Feferbaum R; Diniz EM; Okay TS; Ceccon ME; Costa Vaz FA
Rev Hosp Clin Fac Med Sao Paulo; 2001; 56(1):17-24. PubMed ID: 11378679
[TBL] [Abstract][Full Text] [Related]
2. Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.
Ringenberg T; Robinson C; Meyers R; Degnan L; Shah P; Siu A; Sturgill M
Pediatr Infect Dis J; 2015 Jul; 34(7):742-7. PubMed ID: 25629890
[TBL] [Abstract][Full Text] [Related]
3. Lack of vancomycin-associated nephrotoxicity in newborn infants: a case-control study.
Bhatt-Mehta V; Schumacher RE; Faix RG; Leady M; Brenner T
Pediatrics; 1999 Apr; 103(4):e48. PubMed ID: 10103340
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin monitoring in term newborns: comparison of peak and trough serum concentrations determined by high performance liquid chromatography and fluorescence polarization immunoassay.
Feferbaum R; Kobol Machado JK; de Albuquerque Diniz EM; Okay TS; Santos SR; Ceccon ME; Krebs VL; de Araújo MC; Costa Vaz A
Rev Hosp Clin Fac Med Sao Paulo; 2001; 56(5):149-52. PubMed ID: 11781595
[TBL] [Abstract][Full Text] [Related]
5. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
Hidayat LK; Hsu DI; Quist R; Shriner KA; Wong-Beringer A
Arch Intern Med; 2006 Oct; 166(19):2138-44. PubMed ID: 17060545
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Vancomycin Use in Late-Onset Neonatal Sepsis Using the Area Under the Concentration-Time Curve to the Minimum Inhibitory Concentration ≥400 Target.
Bhongsatiern J; Stockmann C; Roberts JK; Yu T; Korgenski KE; Spigarelli MG; Desai PB; Sherwin CM
Ther Drug Monit; 2015 Dec; 37(6):756-65. PubMed ID: 26562817
[TBL] [Abstract][Full Text] [Related]
7. Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?
Padari H; Oselin K; Tasa T; Metsvaht T; Lõivukene K; Lutsar I
BMC Pediatr; 2016 Dec; 16(1):206. PubMed ID: 27931193
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin population pharmacokinetics in neonates.
de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
[TBL] [Abstract][Full Text] [Related]
9. Inadequate vancomycin therapy in term and preterm neonates: a retrospective analysis of trough serum concentrations in relation to minimal inhibitory concentrations.
Sinkeler FS; de Haan TR; Hodiamont CJ; Bijleveld YA; Pajkrt D; Mathôt RA
BMC Pediatr; 2014 Jul; 14():193. PubMed ID: 25066951
[TBL] [Abstract][Full Text] [Related]
10. Vancomycin dosage requirements among pediatric intensive care unit patients with normal renal function.
Glover ML; Cole E; Wolfsdorf J
J Crit Care; 2000 Mar; 15(1):1-4. PubMed ID: 10757191
[TBL] [Abstract][Full Text] [Related]
11. Dose regimen for vancomycin not needing serum peak levels?
Tan WH; Brown N; Kelsall AW; McClure RJ
Arch Dis Child Fetal Neonatal Ed; 2002 Nov; 87(3):F214-6. PubMed ID: 12390995
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin serum concentrations in pediatric oncologic/hematologic intensive care patients.
Silva DC; Seixas GT; Araujo OR; Arduini RG; Carlesse FA; Petrilli AS
Braz J Infect Dis; 2012; 16(4):361-5. PubMed ID: 22846125
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of clinical outcome in children and adolescents receiving vancomycin for invasive infections due to methicillin-resistant Staphylococcus aureus: impact of increasing vancomycin MICs.
Arun A; Swamy S; Jacob K; Sharma R; Kohlhoff SA; Hammerschlag MR
Minerva Pediatr; 2018 Jun; 70(3):207-211. PubMed ID: 28006894
[TBL] [Abstract][Full Text] [Related]
14. Comparison of two gentamicin dosing schedules in very low birth weight infants.
Rastogi A; Agarwal G; Pyati S; Pildes RS
Pediatr Infect Dis J; 2002 Mar; 21(3):234-40. PubMed ID: 12005088
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic monitoring of vancomycin in routine clinical practice].
Kacířová I; Grundmann M
Vnitr Lek; 2014 Oct; 60(10):846-51. PubMed ID: 25382007
[TBL] [Abstract][Full Text] [Related]
16. A seven-year survey of management of coagulase-negative staphylococcal sepsis in the neonatal intensive care unit: vancomycin may not be necessary as empiric therapy.
Hemels MA; van den Hoogen A; Verboon-Maciolek MA; Fleer A; Krediet TG
Neonatology; 2011; 100(2):180-5. PubMed ID: 21455008
[TBL] [Abstract][Full Text] [Related]
17. Comparison of vancomycin and teicoplanin for prophylaxis of sepsis with coagulase negative staphylococci (CONS) in very low birth weight (VLBW) infants.
Möller JC; Nelskamp I; Jensen R; Reiss I; Kohl M; Gatermann S; Iven H; Gortner L
J Perinat Med; 1997; 25(4):361-7. PubMed ID: 9350607
[TBL] [Abstract][Full Text] [Related]
18. One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates.
Rao SC; Ahmed M; Hagan R
Cochrane Database Syst Rev; 2006 Jan; (1):CD005091. PubMed ID: 16437518
[TBL] [Abstract][Full Text] [Related]
19. Should the Vancomycin Minimal Inhibitory Concentration be used as an Infant Critical Care Regular Criteria?
Bidu NS; Fernandes BJD; Filho JNC; Bastos REA; Pedreira JNR; Couto RD
Curr Pharm Biotechnol; 2020; 21(11):1052-1058. PubMed ID: 32216735
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.
Rybak MJ; Lomaestro BM; Rotschafer JC; Moellering RC; Craig WA; Billeter M; Dalovisio JR; Levine DP
Pharmacotherapy; 2009 Nov; 29(11):1275-9. PubMed ID: 19873687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
